表纸
市场调查报告书
商品编码
1069453

人工呼吸器的全球市场:现状分析与预测(2021年~2027年)

Ventilator Market: Current Analysis and Forecast (2021-2027)

出版日期: | 出版商: UnivDatos Market Insights Pvt Ltd | 英文 244 Pages | 商品交期: 最快1-2个工作天内

价格
  • 全貌
  • 简介
  • 目录
简介

全球人工呼吸器的市场规模,在预测期间(2021年~2027年)预计将以约8%的年复合成长率成长。

在哮喘和慢性阻塞性肺病发病率上升、老龄化社会的到来、吸烟率上升、城市化和污染以及生活方式改变的背景下,市场正在显著增长。随著慢性呼吸系统疾病发病率的增加,预计老年人口的激增将推动对呼吸机的需求。

本报告提供全球人工呼吸器市场的相关调查,提供市场摘要,市场洞察,市场机会,竞争模式,企业概要等全面性资讯。

目录

第1章 市场简介

  • 市场定义
  • 限制
  • 相关利益者
  • 报告所使用的货币

第2章 调查手法或假设

  • 人工呼吸器市场调查流程
  • 人工呼吸器市场调查手法
  • 预测方法
  • 受访者简介
  • 人工呼吸器市场调查的主要目的

第3章 市场摘要

第4章 摘要整理

第5章 人工呼吸器市场COVID-19影响

第6章 人工呼吸器市场收益(美元)(2019年~2027年)

第7章 按市场洞察:行动

  • 加护治疗用人工呼吸器
  • 可携式/可携式呼吸器

第8章 市场洞察:各类型

  • 成人/儿童用人工呼吸器
  • 新生儿/婴儿用人工呼吸器

第9章 市场洞察:各介面

  • 侵入性
  • 非侵入性

第10章 市场洞察:各终端用户

  • 医院和诊所
  • 门诊病人诊疗中心
  • 居家医疗
  • 其他

第11章 市场洞察:各地区

  • 北美的人工呼吸器市场
    • 美国
    • 加拿大
  • 欧洲的人工呼吸器市场
    • 德国
    • 英国
    • 法国
    • 西班牙
    • 义大利
    • 其他的欧洲
  • 亚太地区的人工呼吸器市场
    • 中国
    • 日本
    • 印度
    • 澳洲
    • 纽西兰
    • 其他的亚太地区
  • 其他

第12章 人工呼吸器市场市场动态

  • 推动市场要素
  • 市场课题
  • 影响分析

第13章 人工呼吸器的市场机会

第14章 人工呼吸器的市场趋势

第15章 相关法规

第16章 需求与供给面的分析

  • 需求面分析
  • 供给面分析

第17章 价值链分析

第18章 竞争模式

  • 竞争占有率分析
    • 全球市场占有率:各收益
    • 地区的市场占有率:各收益

第19章 企业概要

  • Koninklijke Philips N.V.
  • Medtronic plc
  • Vyaire Medical Inc.
  • GE Healthcare
  • Fisher & Paykel Healthcare Limited
  • Smiths Group plc
  • Dragerwerk AG & CO. KGAA
  • Getinge AB
  • Resmed
  • Hamilton Medical

第20章 免责声明

目录
Product Code: UMHE21731

A ventilator, breathing machine, or respirator is a machine that assists with breathing. It is mainly used in hospitals to treat chronic obstructive pulmonary disease (COPD), sleep apnea, acute lung injury, and hypoxemia. The market is experiencing significant growth on account of the rising incidence of Asthma and COPD cases, rise in the aging population, increasing prevalence of tobacco smoking, growing urbanization and pollution, and lifestyle changes.

Ventilator Market is expected to exceed the market valuation of more than US$ XX billion in 2027 and is expected to grow at a significant CAGR of 8% during the forecast period (2021-2027). The surging elderly population along with the growing incidence of chronic respiratory disorders is anticipated to boost the demand for ventilators. Significant rising awareness of lung cancer symptoms and an increase in hospital admissions will fortify the demand for excellent treatment choices offering enormous growth opportunities. Furthermore, the global market is witnessing an uptick on account of the surging prevalence of the cardiovascular disease, the aging population, and other cardio-related problems that increases the possibility of cardiac arrest. As per the WHO, CVDs are the number 1 cause of death globally and approximately 31% of total deaths happened due to CVDs. Moreover, the rising global aging population who are more prone to the diseases are acting as a growth catalyst to the industry.

With the increase in population and urbanization, air pollution is becoming the major public health concern all over the world. Exposure to the harmful chemicals present in the air leads to significant adverse effects on health. Air pollutants are the major cause of asthma and chronic obstructive pulmonary disease (COPD) like chronic diseases. These pollutants not only lead to the acute aggravation of Asthma and COPD attacks but also increases the rate of respiratory morbidity and mortality. South Asia, East Asia, and the Pacific are the major reasons that experience high mortality rates due to air pollution. In 2019, the exposure to air pollutants resulted in more than two million deaths in these regions, with high death rates in China and India.

Some of the major players operating in the market include: Koninklijke Philips N.V., Medtronic, Vyaire Medical Inc., GE Healthcare, Fisher & Paykel Healthcare Limited, Smiths Group plc, Dragerwerk AG & CO. KGAA, Getinge AB, Resmed, and Hamilton Medical. Several M&As along with partnerships have been undertaken by these players to boost their presence in different regions.

Insights Presented in the Report

"Amongst Mobility, Intensive care ventilators category held the major share"

Based on mobility, the Ventilator Market is categorized into Intensive care ventilators and Portable/transportable ventilators. In 2020, Intensive care ventilators category accounted for the majority share in the market. This is mainly attributed to the presence of various manufacturers and initiatives taken by government to increase the production of ventilators to provide care for patients with serious respiratory diseases and increasing number of ICU beds, have propelled the growth of the market.

However, portable/transportable ventilators category to witness higher CAGR during the forecast period. Portable ventilators are used to deliver oxygen to patients when required. These ventilators are used in hospitals and day care centers for continuous oxygen supply when a COPD patient is unconsciousness or when there is discomfort due to breathing problems. Rise in hospital admissions owing to increase in incidence of COPD and surge in emphasis on home care are projected to drive the portable ventilators segment.

"Amongst Type, Cloud Based (SAAS) Model Segment holds the major share"

Based on type, the market has been bifurcated into Adult ventilators and Neonatal/infant ventilators. In 2020, Adult/pediatric ventilators accounted for a higher market valuation of US$ XX billion in 2020. This is mainly due to the growing incidence of chronic diseases such as COPD & asthma in adult population coupled with the growing number of smoker and the rising number of lung cancer cases in geriatric population.

In addition, increase in government expenditure on health care provides citizens with access to health care services at affordable cost. This is a crucial factor boosting the respiratory devices/products market in emerging economies. According to WHO statistics, per capita health care expenditure has risen across the globe. The health care expenditure in South Africa increased from 8.5% to 8.8% of the GDP from 2013 to 2017. Furthermore, Thus, the rising number of hospitals and ICU beds is also expected to fuel the segment growth.

"Amongst End-User, Hospitals and Clinics segment holds the major share"

Based on End-User, the Ventilator Market is categorized into Hospitals & clinics, Ambulatory care centers, Home Care, and Others. Amongst End-User, the Hospital and Clinics category accounted for the significant share in the market owing to the attributed to the financial capabilities of hospitals to purchase high-priced instruments and the availability of trained professionals to operate ventilators. Moreover, rise in number of patients affected by sudden cardiac arrest coupled with the geriatric population globally is resulting in the increasing need for advance healthcare facilities and clinics. As per the Journal of Thoracic and Cardiovascular surgery, around 75% of the world does not have access to cardiac surgery when needed because of lack of infrastructure, human resources, and financial coverage. Therefore, the government across countries are investing more in healthcare for better infrastructure and services. For instance, Total healthcare expenditure increased from USD 186.5 per capita in 2010 to USD 501.1 per capita in 2019, in China. Whereas, per capita healthcare expenditure in U.S. was above USD 10,000 in 2019. Thus, showing great potential for market players to grow and increase their market presence, during the forecast period.

"North America represents one of the largest markets of Ventilator market"

For a better understanding of the market dynamics of the Ventilator market, a detailed analysis was conducted for different regions across India including North America (US, Canada), Europe (Germany, UK, France, Spain, Italy, Rest of Europe), Asia-Pacific (China, Japan, India, Australia, New Zealand, Rest of Asia-Pacific), Rest of World. North America dominated the market owing to the rising number of patients admitted to intensive care and critical care units every year. Additionally, the reimbursement policies offered by the governments of Canada and the U.S. are also aiding in the expansion of this regional market. In addition, rising incidence rate of respiratory diseases among the region's population is expected to force policy makers to invest in new and advance medical devices for the treatment of patients, thus decreasing the mortality rate. Though respiratory disease is one of the leading causes of morbidity and mortality among non-communicable diseases, most major respiratory conditions are preventable. Much of the respiratory conditions can be mitigated by improved screening and early diagnosis of patients/public, especially in the smoking population. Therefore, creating tremendous opportunities for the market players during the 2020-2027.

Reasons to buy this report:

The study includes market sizing and forecasting analysis validated by authenticated key industry experts

The report presents a quick review of overall industry performance at one glance

The report covers an in-depth analysis of prominent industry peers with a primary focus on key business financials, product portfolio, expansion strategies, and recent developments

Detailed examination of drivers, restraints, key trends, and opportunities prevailing in the industry

The study comprehensively covers the market across different segments

Deep dive regional level analysis of the industry

Customization Options:

Ventilator market can further be customized as per the requirement or any other market segment. Besides this, UMI understands that you may have your own business needs, hence feel free to connect with us to get a report that completely suits your requirements.

TABLE OF CONTENTS

1 MARKET INTRODUCTION

  • 1.1. Market Definitions
  • 1.2. Limitation
  • 1.3. Stake Holders
  • 1.4. Currency used in Report

2 RESEARCH METHODOLOGY OR ASSUMPTION

  • 2.1. Research Process of the Ventilator Market
  • 2.2. Research Methodology of the Ventilator Market
  • 2.3. Forecasting Method
  • 2.4. Respondent Profile
  • 2.5. Main Objective of the Ventilator Market Study

3 MARKET SYNOPSIS

4 EXECUTIVE SUMMARY

5 VENTILATOR MARKET COVID-19 IMPACT

6 VENTILATOR MARKET REVENUE (USD), 2019-2027F

7 MARKET INSIGHTS BY MOBILITY

  • 7.1. Intensive care ventilators
  • 7.2. Portable/ transportable ventilators

8 MARKET INSIGHTS BY TYPE

  • 8.1. Adult/pediatric ventilators
  • 8.2. Neonatal/infant ventilators

9 MARKET INSIGHTS BY INTERFACE

  • 9.1. Invasive ventilation
  • 9.2. Non-invasive ventilation

10 MARKET INSIGHTS BY END-USER

  • 10.1. Hospitals & clinics
  • 10.2. Ambulatory care centers
  • 10.3. Home Care
  • 10.4. Others

11 MARKET INSIGHTS BY REGION

  • 11.1. NORTH AMERICA VENTILATOR MARKET
    • 11.1.1. United States
      • 11.1.1.1. Company Share Analysis, By Revenue
    • 11.1.2. Canada
      • 11.1.2.1. Company Share Analysis, By Revenue
  • 11.2. EUROPE VENTILATOR MARKET
    • 11.2.1. Germany
      • 11.2.1.1. Company Share Analysis, By Revenue
    • 11.2.2. United Kingdom
      • 11.2.2.1. Company Share Analysis, By Revenue
    • 11.2.3. France
      • 11.2.3.1. Company Share Analysis, By Revenue
    • 11.2.4. Spain
      • 11.2.4.1. Company Share Analysis, By Revenue
    • 11.2.5. Italy
      • 11.2.5.1. Company Share Analysis, By Revenue
    • 11.2.6. Rest of Europe
  • 11.3. ASIA-PACIFIC VENTILATOR MARKET
    • 11.3.1. China
      • 11.3.1.1. Company Share Analysis, By Revenue
    • 11.3.2. Japan
      • 11.3.2.1. Company Share Analysis, By Revenue
    • 11.3.3. India
      • 11.3.3.1. Company Share Analysis, By Revenue
    • 11.3.4. Australia
      • 11.3.4.1. Company Share Analysis, By Revenue
    • 11.3.5. New Zealand
      • 11.3.5.1. Company Share Analysis, By Revenue
    • 11.3.6. Rest of Asia-Pacific
  • 11.4. REST OF THE WORLD VENTILATOR MARKET

12 VENTILATOR MARKET DYNAMICS

  • 12.1. Market Drivers
  • 12.2. Market Challenges
  • 12.3. Impact Analysis

13 VENTILATOR MARKET OPPORTUNITIES

14 VENTILATOR MARKET TRENDS

15 LEGAL & REGULATORY FRAMEWORK

16 DEMAND AND SUPPLY SIDE ANALYSIS

  • 16.1. Demand Side Analysis
  • 16.2. Supply Side Analysis

17 VALUE CHAIN ANALYSIS

18 COMPETITIVE SCENARIO

  • 18.1. Competitive Share Analysis
    • 18.1.1. Global Market Share, By Revenue
    • 18.1.2. Regional Market Share, By Revenue
      • 18.1.2.1. North America
      • 18.1.2.2. Europe
      • 18.1.2.3. APAC

19 COMPANY PROFILED

  • 19.1. Koninklijke Philips N.V.
  • 19.2. Medtronic plc
  • 19.3. Vyaire Medical Inc.
  • 19.4. GE Healthcare
  • 19.5. Fisher & Paykel Healthcare Limited
  • 19.6. Smiths Group plc
  • 19.7. Dragerwerk AG & CO. KGAA
  • 19.8. Getinge AB
  • 19.9. Resmed
  • 19.10. Hamilton Medical

20 DISCLAIMER